US Stock MarketDetailed Quotes

IMUC EOM Pharmaceutical Holdings

Watchlist
  • 0.197900
  • 0.0000000.00%
15min DelayTrading Apr 26 16:00 ET
22.42MMarket Cap0.01P/E (TTM)

EOM Pharmaceutical Holdings Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2018
(Q1)Mar 31, 2018
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
(Q3)Sep 30, 2017
(Q2)Jun 30, 2017
(Q1)Mar 31, 2017
(FY)Dec 31, 2016
(Q4)Dec 31, 2016
(Q3)Sep 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
37.04%-2.17M
73.59%-1.6M
16.07%-16.67M
-31.75%-4.93M
54.97%-2.22M
40.91%-3.45M
-13.45%-6.07M
-4.33%-19.86M
35.67%-3.74M
21.96%-4.93M
Net income from continuing operations
92.43%-306.7K
82.71%-1.02M
35.20%-14.31M
93.18%-431.3K
18.69%-3.9M
23.97%-4.05M
-5.23%-5.93M
-72.67%-22.09M
-31.50%-6.32M
-41.06%-4.8M
Operating gains losses
----
----
100.04%1.71K
--0
----
----
----
-30.33%-3.81M
----
----
Depreciation and amortization
-99.36%106
-99.36%106
-36.41%47.77K
-96.23%637
-19.21%13.94K
-19.41%16.6K
-18.53%16.6K
107.54%75.11K
6.18%16.9K
146.62%17.26K
Other non cash items
----
----
-477.65%-6.84M
--0
--0
-4,856.46%-7.29M
324.59%452.66K
712.39%1.81M
14.67%2.82M
-95.95%-664.53K
Change In working capital
-135.94%-1.93M
20.08%-626.43K
-45.67%1.59M
-247.35%-4.55M
551.84%1.55M
938.29%5.37M
-431.89%-783.81K
164.89%2.92M
486.28%3.09M
108.39%237.31K
-Change in inventory
----
----
166.09%146.43K
--0
----
----
----
89.97%-221.55K
--156.29K
---84.74K
-Change in payables and accrued expense
-115.04%-956.93K
25.91%-867.59K
-201.61%-928.72K
-419.99%-4.88M
-1,389.54%-1.24M
1,007.55%6.36M
-19,081.20%-1.17M
-3.41%914.04K
561.52%1.53M
-91.88%96.13K
-Change in other current assets
-152.66%-352.03K
-18.88%241.16K
39,768.89%2.37M
----
----
---139.33K
--297.3K
-98.59%5.94K
----
----
-Change in other working capital
----
----
----
----
--2.8M
---851.69K
-84.98%89.9K
160.71%2.22M
84.78%1.4M
----
Cash from discontinued investing activities
Operating cash flow
37.04%-2.17M
73.59%-1.6M
16.07%-16.67M
-31.75%-4.93M
54.97%-2.22M
40.91%-3.45M
-13.45%-6.07M
-4.33%-19.86M
35.67%-3.74M
21.96%-4.93M
Investing cash flow
Cash flow from continuing investing activities
133.03%1.33K
0
97.63%-4.02K
0
0
Net PPE purchase and sale
----
----
133.03%1.33K
--0
----
----
----
97.63%-4.02K
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
133.03%1.33K
--0
----
----
----
97.63%-4.02K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
36.34%11.86M
4,739.01%5.55M
-22.57%6.41M
-126.85%-74.6K
-109.57%-25.33K
-53.20%8.7M
-103.00%-119.71K
122,541.21%8.28M
Net common stock issuance
----
----
----
----
----
----
----
-51.80%7.04M
-4,103.72%-283.75K
98,116.58%6.63M
Net preferred stock issuance
----
----
--4.05M
---72.5K
----
----
----
----
----
----
Proceeds from stock option exercised by employees
----
----
3,643.77%7.82M
2,595.06%5.63M
--2.15M
----
----
2,992.59%208.75K
--208.75K
--0
Net other financing activities
----
----
----
----
----
---115.6K
---25.33K
-63.48%1.46M
---44.71K
--1.65M
Cash from discontinued financing activities
Financing cash flow
--0
--0
36.34%11.86M
4,739.01%5.55M
-22.57%6.41M
-126.85%-74.6K
-109.57%-25.33K
-53.20%8.7M
-103.00%-119.71K
122,541.21%8.28M
Net cash flow
Beginning cash position
-5.89%5.03M
-42.03%6.63M
-49.40%11.44M
-60.74%6.01M
-84.82%1.81M
-69.50%5.34M
-49.40%11.44M
-2.66%22.6M
-37.39%15.3M
-61.34%11.95M
Current changes in cash
38.37%-2.17M
73.70%-1.6M
56.95%-4.81M
116.18%624.57K
25.15%4.19M
36.62%-3.53M
-19.75%-6.1M
-1,707.56%-11.17M
-110.89%-3.86M
151.74%3.35M
End cash Position
57.25%2.85M
-5.89%5.03M
-42.03%6.63M
-42.03%6.63M
-60.74%6.01M
-84.82%1.81M
-69.50%5.34M
-49.40%11.44M
-49.40%11.44M
-37.39%15.3M
Free cash flow
37.04%-2.17M
73.59%-1.6M
16.09%-16.67M
-31.75%-4.93M
54.97%-2.22M
40.91%-3.45M
-13.36%-6.07M
-3.43%-19.87M
35.67%-3.74M
23.93%-4.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2018(Q1)Mar 31, 2018(FY)Dec 31, 2017(Q4)Dec 31, 2017(Q3)Sep 30, 2017(Q2)Jun 30, 2017(Q1)Mar 31, 2017(FY)Dec 31, 2016(Q4)Dec 31, 2016(Q3)Sep 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 37.04%-2.17M73.59%-1.6M16.07%-16.67M-31.75%-4.93M54.97%-2.22M40.91%-3.45M-13.45%-6.07M-4.33%-19.86M35.67%-3.74M21.96%-4.93M
Net income from continuing operations 92.43%-306.7K82.71%-1.02M35.20%-14.31M93.18%-431.3K18.69%-3.9M23.97%-4.05M-5.23%-5.93M-72.67%-22.09M-31.50%-6.32M-41.06%-4.8M
Operating gains losses --------100.04%1.71K--0-------------30.33%-3.81M--------
Depreciation and amortization -99.36%106-99.36%106-36.41%47.77K-96.23%637-19.21%13.94K-19.41%16.6K-18.53%16.6K107.54%75.11K6.18%16.9K146.62%17.26K
Other non cash items ---------477.65%-6.84M--0--0-4,856.46%-7.29M324.59%452.66K712.39%1.81M14.67%2.82M-95.95%-664.53K
Change In working capital -135.94%-1.93M20.08%-626.43K-45.67%1.59M-247.35%-4.55M551.84%1.55M938.29%5.37M-431.89%-783.81K164.89%2.92M486.28%3.09M108.39%237.31K
-Change in inventory --------166.09%146.43K--0------------89.97%-221.55K--156.29K---84.74K
-Change in payables and accrued expense -115.04%-956.93K25.91%-867.59K-201.61%-928.72K-419.99%-4.88M-1,389.54%-1.24M1,007.55%6.36M-19,081.20%-1.17M-3.41%914.04K561.52%1.53M-91.88%96.13K
-Change in other current assets -152.66%-352.03K-18.88%241.16K39,768.89%2.37M-----------139.33K--297.3K-98.59%5.94K--------
-Change in other working capital ------------------2.8M---851.69K-84.98%89.9K160.71%2.22M84.78%1.4M----
Cash from discontinued investing activities
Operating cash flow 37.04%-2.17M73.59%-1.6M16.07%-16.67M-31.75%-4.93M54.97%-2.22M40.91%-3.45M-13.45%-6.07M-4.33%-19.86M35.67%-3.74M21.96%-4.93M
Investing cash flow
Cash flow from continuing investing activities 133.03%1.33K097.63%-4.02K00
Net PPE purchase and sale --------133.03%1.33K--0------------97.63%-4.02K--0--0
Cash from discontinued investing activities
Investing cash flow --------133.03%1.33K--0------------97.63%-4.02K--0--0
Financing cash flow
Cash flow from continuing financing activities 0036.34%11.86M4,739.01%5.55M-22.57%6.41M-126.85%-74.6K-109.57%-25.33K-53.20%8.7M-103.00%-119.71K122,541.21%8.28M
Net common stock issuance -----------------------------51.80%7.04M-4,103.72%-283.75K98,116.58%6.63M
Net preferred stock issuance ----------4.05M---72.5K------------------------
Proceeds from stock option exercised by employees --------3,643.77%7.82M2,595.06%5.63M--2.15M--------2,992.59%208.75K--208.75K--0
Net other financing activities -----------------------115.6K---25.33K-63.48%1.46M---44.71K--1.65M
Cash from discontinued financing activities
Financing cash flow --0--036.34%11.86M4,739.01%5.55M-22.57%6.41M-126.85%-74.6K-109.57%-25.33K-53.20%8.7M-103.00%-119.71K122,541.21%8.28M
Net cash flow
Beginning cash position -5.89%5.03M-42.03%6.63M-49.40%11.44M-60.74%6.01M-84.82%1.81M-69.50%5.34M-49.40%11.44M-2.66%22.6M-37.39%15.3M-61.34%11.95M
Current changes in cash 38.37%-2.17M73.70%-1.6M56.95%-4.81M116.18%624.57K25.15%4.19M36.62%-3.53M-19.75%-6.1M-1,707.56%-11.17M-110.89%-3.86M151.74%3.35M
End cash Position 57.25%2.85M-5.89%5.03M-42.03%6.63M-42.03%6.63M-60.74%6.01M-84.82%1.81M-69.50%5.34M-49.40%11.44M-49.40%11.44M-37.39%15.3M
Free cash flow 37.04%-2.17M73.59%-1.6M16.09%-16.67M-31.75%-4.93M54.97%-2.22M40.91%-3.45M-13.36%-6.07M-3.43%-19.87M35.67%-3.74M23.93%-4.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg